SPONSOR
University of Tennessee Graduate School of Medicine
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Peripheral Arterial DiseasePreeclampsiaGestational Diabetes Mellitus (GDM)Preeclampsia (PE)Preeclampsia (PE) RiskGestational DiabetesGestational Diabetes Mellitus in PregnancyCardiometabolic DiseasesInsulin ResistancePlacental Dysfunction
University of Tennessee Graduate School of Medicine is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Peripheral Arterial Disease, Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Tennessee Graduate School of Medicine
How many clinical trials has University of Tennessee Graduate School of Medicine sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University of Tennessee Graduate School of Medicine, of which 3 are actively recruiting participants. These trials cover conditions including Peripheral Arterial Disease, Preeclampsia, Gestational Diabetes Mellitus (GDM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Tennessee Graduate School of Medicine research focus on?
University of Tennessee Graduate School of Medicine clinical trials span Peripheral Arterial Disease, Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a University of Tennessee Graduate School of Medicine clinical trial?
To participate in a University of Tennessee Graduate School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Tennessee Graduate School of Medicine trials with current recruitment status updated daily.
Clinical Trials by University of Tennessee Graduate School of Medicine
NCT07223437
Recruiting
REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
Peripheral Arterial Disease
NCT07565727
Recruiting
Cardiometabolic Disease and Substrate Metabolism
Preeclampsia
NCT07153614
Recruiting
Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy
Perioperative Opioid Sparing Techniques
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology